Expressions of junB and c-fos are enhanced in 4-nitroquinoline 1-oxide-induced rat tongue cancers

被引:11
作者
Ohyama, M
Hirayama, Y
Tanuma, J
Hirano, M
Semba, I
Shisa, H
Hiai, H
Sugihara, K
Kitano, M
机构
[1] Kagoshima Univ, Sch Dent, Dept Oral Pathol, Kagoshima 8908544, Japan
[2] Kagoshima Univ, Sch Dent, Dept Oral & Maxillofacial Surg 1, Kagoshima 8908544, Japan
[3] Saitama Canc Ctr, Res Inst, Lab Basic Canc Study, Saitama, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan
关键词
4-nitroquinoline 1-oxide (4NQO); c-fos; junB; rat tongue cancer; Tscc1;
D O I
10.1046/j.1440-1827.2003.01587.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Activator protein-1 (AP-1) is a transcription factor activated in many tumors. Using 4-nitroquinoline 1-oxide (4NQO)-induced rat tongue cancers (TC), the present study investigated the expression levels of genes that encode the components of AP-1, the jun gene family (c-jun, junB and junD) and the fos gene family (c-fos, fra-1, fra-2 and fosB). Expression levels of junB and c-fos mRNAs in TC were significantly elevated compared with those in epithelial tissue of control rat tongue, although only c-fos mRNA levels tended to be elevated in dysplastic tongue epithelium. Histologically, all 4NQO-induced rat TC were well-differentiated squamous cell carcinomas. Immunostaining for JunB and c-Fos proteins was positive in the nuclei of tumor cells of all TC. It is noteworthy that JunB was negative, but c-Fos was positive in the dysplastic tongue epithelium of the 4NQO-treated rats. Immunostaining for both proteins was negative in tongue mucosal epithelium of control rats. There were no mutations in the coding regions of either junB or c-fos in all the TC examined. These results suggest the possibility that the expressions of junB and c-fos were enhanced stepwise in 4NQO-induced carcinogenesis of rat tongue, and that the coexpression of JunB and c-Fos might play an important role in the establishment of TC.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 34 条
[11]   Identification of SWI•SNF complex subunit BAF60a as a determinant of the transactivation potential of Fos/Jun dimers [J].
Ito, T ;
Yamauchi, M ;
Nishina, M ;
Yamamichi, N ;
Mizutani, T ;
Ui, M ;
Murakami, M ;
Iba, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (04) :2852-2857
[12]   AP-1 in mouse development and tumorigenesis [J].
Jochum, W ;
Passegué, E ;
Wagner, EF .
ONCOGENE, 2001, 20 (19) :2401-2412
[13]   STRAIN DIFFERENCE OF SUSCEPTIBILITY TO 4-NITROQUINOLINE 1-OXIDE-INDUCED TONGUE CARCINOMA IN RATS [J].
KITANO, M ;
HATANO, H ;
SHISA, H .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (08) :843-850
[14]   Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation [J].
Li, BY ;
Tournier, C ;
Davis, RJ ;
Flavell, RA .
EMBO JOURNAL, 1999, 18 (02) :420-432
[15]  
Miller C, 1998, J CELL BIOCHEM, V69, P392, DOI 10.1002/(SICI)1097-4644(19980615)69:4<392::AID-JCB2>3.0.CO
[16]  
2-I
[17]   Enhanced expression of neuron-specific enolase (NSE) in pyothorax-associated lymphoma (PAL) [J].
Nakatsuka, S ;
Nishiu, M ;
Tomita, Y ;
Miwa, H ;
Takakuwa, T ;
Iuchi, K ;
Yamamoto, S ;
Aozasa, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (04) :411-416
[18]  
Neyns B, 1996, ONCOGENE, V12, P1247
[19]   JunB can substitute for Jun in mouse development and cell proliferation [J].
Passegué, E ;
Jochum, W ;
Behrens, A ;
Ricci, R ;
Wagner, EF .
NATURE GENETICS, 2002, 30 (02) :158-166
[20]  
PINDBORG JJ, 1997, HISTOLOGICAL TYPING, P24